{"id":771,"count":8,"description":"OncoTrace\u2122 Recombinant Monoclonal Antibodies - EasyPath\nThe Future of Immunohistochemistry with Diagnostic Clarity\nThe <strong>recombinant monoclonal antibodies<\/strong> of the <strong>OncoTrace\u2122<\/strong> line, made exclusively by <strong>EasyPath<\/strong>, represent the new generation of reagents for <strong>immunohistochemical (IHQ)<\/strong> cancer diagnostics. Produced in vitro with bioengineering technology, they deliver stable performance, consistent results and greater reliability for pathologists seeking precision and reproducibility. \nWhat are Recombinant Antibodies?\n<strong>Recombinant antibodies<\/strong> are produced by genetic engineering in controlled systems, without the need for hybridomas or the use of animals. This guarantees standardization, purity and uniformity in each batch, reducing variations in laboratory results and increasing the quality of histopathological diagnosis. \nDifference between Hybridoma Antibodies and Recombinant Monoclonal Antibodies\n\n\n\nAspect\nRecombinant Monoclonal Antibodies (OncoTrace\u2122)\nTraditional Hybridoma Antibodies\n\n\n\n\nOrigin\nProduced in vitro, without animal use\nDerived from hybridomas in animal models\n\n\nConsistency\nAbsolute batch-to-batch reproducibility\nHigh variability between batches\n\n\nReactivity\nLess cross-reactivity and non-specific background\nHigher risk of false positives\n\n\nScalability\nUnlimited, standardized production\nDependence on cell colonies\n\n\n\nBenefits of the Recombinant Antibody in the IHQ Technique\n\n \tClean, clear staining with no nonspecific background\n \tHigh sensitivity and specificity in cancer diagnosis\n \tStability and reliability in all batches\n \tReduction of false negatives and greater diagnostic clarity\n \tSustainable and animal cruelty-free production\n\nWhy Choose OncoTrace\u2122 Recombinant Antibodies?\nBy opting for OncoTrace\u2122 <strong>recombinant monoclonal antibodies<\/strong>, the laboratory ensures clearer, standardized and reproducible diagnoses. This innovation takes the practice of <strong>immunohistochemistry<\/strong> to a new level, reducing uncertainty and optimizing clinical decision-making in oncology. \nWhat is the advantage for routine diagnostics?\nGreater reliability, clarity in staining and absolute standardization, optimizing the pathologist's time and reducing rework.\nTransform your Diagnosis with OncoTrace\u2122\nThe <strong>OncoTrace\u2122 EasyPath<\/strong> line delivers the latest in <strong>recombinant monoclonal antibodies<\/strong>, combining innovation, reliability and cost-effectiveness.\nRequest a quote now and raise the quality of your immunohistochemistry.","link":"https:\/\/easypath.com.br\/en\/product-category\/immunohistochemistry-and-hybridization\/antibodies\/oncotrace-recombinant-antibodies\/","name":"OncoTrace\u2122 Recombinant Antibodies","slug":"oncotrace-recombinant-antibodies","taxonomy":"product_cat","parent":421,"meta":[],"_links":{"self":[{"href":"https:\/\/easypath.com.br\/en\/wp-json\/wp\/v2\/product_cat\/771","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/easypath.com.br\/en\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/easypath.com.br\/en\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"up":[{"embeddable":true,"href":"https:\/\/easypath.com.br\/en\/wp-json\/wp\/v2\/product_cat\/421"}],"wp:post_type":[{"href":"https:\/\/easypath.com.br\/en\/wp-json\/wp\/v2\/product?product_cat=771"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}